Our Philosophy: Quality and Patients First.
  • A A A Text Size
  • Print Print
    • .
    • .
    • .
    • .
    • .
    Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients.

    Ranbaxy is a member of the Daiichi Sankyo Group. Daiichi Sankyo is a leading global pharma innovator, headquartered in Tokyo, Japan.
    Read More

    Watch video on how Ranbaxy & APICON created the new Guinness World Record

    Watch a video on how Ranbaxy & APICON created the new Guinness World Record.

    Latest News

    Ranbaxy to sell Epirus arthritis biosimilar in India, emerging markets Mint Jan 09, 2014: India’s largest drugmaker by sales, Ranbaxy Laboratories Ltd, said on Thursday it had signed a licensing agreement to sell drug...

    Ranbaxy to market biosimilar in India and other emerging markets The Times of India Jan 09, 2014: Ranbaxy Laboratories and Epirus Switzerland, a wholly-owned subsidiary of Boston-based Epirus Biopharmaceuticals, announced the signing of a licensing agreement...

    Ranbaxy ropes in Kumble to promote healthy heart Business Standard Dec 06, 2013: Pharma multinational Ranbaxy Laboratories Ltd Friday roped in former Indian captain Anil Kumble in promoting fitness and a healthy heart...

    Ranbaxy ropes in Kumble to promote healthy heart Yahoo.Com Dec 06, 2013: Pharma multinational Ranbaxy Laboratories Ltd Friday roped in former Indian captain Anil Kumble in promoting fitness and a healthy heart...

    Ranbaxy Science Foundation research workshop held at AIIMS in Delhi indiatoday.in Dec 02, 2013: The 30th educational Round Table Conference on "Lifestyle and Cancer with focus on Cancer Prevention"...

    Milkha Singh launches Ranbaxy Diabetes Care Program Business Standard Nov 09, 2013: Legendary athlete Milkha Singh today launched the Ranbaxy Diabetes Care program at annual conference of the Research Society for Study of Diabetes in India (RSSDI) being held at India Expo Centre...

    Ranbaxy gets CDSCO nod to sell malaria drug 'SynriamTM' The Economic Times Oct 21, 2013: Drug major Ranbaxy Laboratories BSE 0.60 % today said it has received Indian drug regulator's approval to market SynriamTM for treating malaria caused by Plasmodium vivax parasite...

    Ranbaxy gets nod to sell new malaria drug The Hindu Business Line Oct 21, 2013: Ranbaxy Laboratories Ltd has received an approval from the Central Drugs Standard Control Organisation to manufacture and market a new drug for the treatment of malaria in adults...

    1 pill for 2 sting parasites The Telegraph Oct 21, 2013: A new synthetic molecule launched by an Indian drug company last year against malaria caused by the Plasmodium falciparum parasite has now also been approved by India’s drug regulators to treat Plasmodium vivax malaria...

    Ranbaxy gets Indian drug regulator's nod to sell malaria drug Hindustan Times Oct 21, 2013: Drug major Ranbaxy Laboratories today said it has received Indian drug regulator's approval to market SynriamTM for treating malaria caused by Plasmodium vivax parasite...

    Ranbaxy drugs safe: India regulator Hindu Business Line Sept 20, 2013: The Indian drugs regulator is confident about the medicines produced by Ranbaxy that are in circulation in the domestic market. Drugs Controller General of...

    No major violations at Ranbaxy's Mohali plant: India's drug regulator Livemint Sept 20, 2013: India’s drug regulator on Thursday said it found no major discrepancies at Ranbaxy Laboratories Ltd’s manufacturing plant in Mohali...

    Explore Ranbaxy
    Press Releases
    Ranbaxy Laboratories Limited, India All Media releases Ranbaxy Laboratories Limited, India Sign up for e-mail alert Ranbaxy Laboratories Limited, India RSS Media releases